If you're a Logic Pro user that's getting frustrated with solely keyboard and mouse-based music-making, Nektar could have the answer. The manufacturer's Panorama CS12 is a dedicated hardware ...

For beginners, it's important to get your head around the basics before jumping deeper, so starting with a free DAW is a great way to get you making music without distractions. Once you know which ...

Lilly partnered with Nektar on the drug in 2017, paying $150 million upfront with another $250 million at the back end in development and regulatory milestones. It has agreed to fund 75% of the ...

Premium construction with genuine beech side-panels. Solid script-based DAW integration. Onboard and software-based customisation. CV connections removed. MusicRadar's got your back Our team of expert ...

Just days after revealing that it was in discussions with Nektar Therapeutics over a possible merger, PureTech Health has said the negotiations have been terminated by mutual agreement. In a ...

Regional integration helps countries overcome divisions that impede the flow of goods, services, capital, people and ideas. These divisions are a constraint to economic growth, especially in ...

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders.

Nékter Juice Bar Prepares for Growth: This award-winning health-focused brand is ready to expand nationwide. Founded upon a promise to reinvent a restaurant category that had lost its way, Nékter ...

Nékter Juice Bar has launched one of its most dramatic lineups ever: “The Golden Trio” in celebration of the premiere of “The Golden Bachelorette,” which debuts Wednesday, September 18 (8 p.m.-10:01 p ...

Stay ahead of the market with features that give you a competitive edge like personalized alerts, earnings reminders, real-time market data so you're ready to take action when the markets move.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...